Developer Submits Premarket Approval Application for TTFields in Pancreatic Cancer
TTFields plus chemotherapy significantly prolonged overall survival compared with chemotherapy alone in patients with pancreatic cancer.
Previous Post
Caught between a (diabetic) hard rock and a (patient charter) hard place
Next Post
STAT+: CDC boosts security in new strategy
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago